divislab glp-1 novo nordisk relation sees pills capturing over third of obesity market by 2030 Novo Nordisk's oral GLP-1 drug

Explore the latest insights on access, mental health, and off-label use in T1D.

PF-07976016 - oral GIPR antagonist Phase 2

Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)

Important note

Causes of Gastritis: Infections: Helicobacter pylori (H

Methylcobalamin (1 mg/mL): A bioactive form of vitamin B12 that supports energy metabolism, nerve function, and red blood cell formation